"This collaboration with Health Discovery Corporation will give us access to new bioinformatics tools for data analysis that will lead to discovery in leukemia. We hope to use these bioinformatics tools to develop new diagnostic approaches for leukemia and improve the clinical management of these patients.
Dr. Herbert Fritsche
Professor and Chief of Clinical Chemistry
MD Anderson Cancer Center

Health Discovery Corporation has identified and patent protected a set of leukemia genes that can separate ALL-T-cell leukemia from ALL-B-cell leukemia with a high degree of accuracy.

Health Discovery Corporation signed an Agreement with The University of Texas, M.D. Anderson Cancer Center in Houston Texas to analyze a gene expression data base to identify new biomarkers and pathways involved in leukemia.

Leukemia is a type of cancer that originates in the bone marrow. The accumulation of malignant cells interferes with the body's production of healthy blood cells and makes the body unable to protect itself against infections. According to the National Cancer Institute (NCI), over 30,000 new cases of leukemia are diagnosed each year in the United States alone.